In agreement with the previous studies, this study has displayed that CD200 (≥30%) incorporation into MS has refined its accuracy to (100%), and therefore, raised its robustness in CLL diagnosis [6,17,21]. The gene discussed is CD200; the disease is B-cell chronic lymphocytic leukemia.